CorFigo, Inc.

About

Corfigo’s mission, simply described, is embedded in the translation of our company name: (‘cor’: heart + ‘figo’: fix, repair, in Latin). We aim to fix hearts that are not working properly, using creativity and technology. Corfigo has developed a potent, novel cryoablation platform to overcome the barriers of current ablation technologies to treat serious heart rhythm disorders.

Product

Value proposition

HeartPad XLT Cryoablation System for epicardial cardiac tissue ablation using liquid helium cryothermal energy, designed for open, MIS surgical and percutaneous procedures with protection of adjacent structures.

Target customers

healthcare providers performing cardiac ablation (surgeons, interventional cardiologists)

Founders

• Deron Siddons — Co-Founder & CEO
• Jason Sperling — Co-Founder

Categories

Products

Key features

Technologies

Target conditions

Care settings

Investors

News

• List of Funded New Jersey Startups in 2026 - Fundraise Insider · 2026-05-23T00:00:00.000Z
• Healthcare innovation focuses on real-world medical needs - LinkedIn · 2026-01-27T00:00:00.000Z
• [PDF] Heart Rhythm 2025: Presenter Disclosures · 2025-05-31T00:00:00.000Z
• Corify Care picks up FDA nod for cardiac mapping tech · 2026-04-17T12:36:26.000Z
• Corify Care Launches First U.S. Clinical Trial (AI4AF) at Mayo Clinic - Corify Care · 2026-06-04T14:07:31.000Z
• Corify Care announces AI collaboration with Mayo Clinic to improve cardiac arrhythmia care - Corify Care · 2025-05-27T08:27:37.000Z

Browse related software

• Clinic software in NJ
• Clinic software in Montclair
• Medical Devices software
• All clinic software companies A–Z